Gilead Sciences (GILD) Change in Inventory (2009 - 2026)
Gilead Sciences' (GILD) quarterly Change in Inventory came in at $52.0 million in Q1 2026, down 76.68% YoY from $223.0 million in Q1 2025, and down 57.72% on a QoQ basis from $123.0 million in Q4 2025.
Gilead Sciences (GILD) Change in Inventory (2009 - 2026) Analysis & Trends
Gilead Sciences (GILD) has 18 years of Change in Inventory data on file, last reported at $52.0 million in Q1 2026.
- Quarterly Change in Inventory fell 76.68% year-over-year to $52.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $865.0 million (up 43.21% YoY) and the FY2025 annual result came in at $1.0 billion, up 143.19% from the prior year.
- Change in Inventory fell to $52.0 million in Q1 2026, from $123.0 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $515.0 million in Q3 2025 to a low of -$53.0 million in Q1 2022.
- A 5-year average of $156.8 million and a median of $123.0 million in 2025 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2022 — Change in Inventory sank 176.81% — and 2023, when it soared 2925.0%.
- Tracing GILD's Change in Inventory over 5 years: stood at $276.0 million in 2022, then rose by 11.23% to $307.0 million in 2023, then dropped by 26.38% to $226.0 million in 2024, then sank by 45.58% to $123.0 million in 2025, then plunged by 57.72% to $52.0 million in 2026.
- The last three Change in Inventory figures came in at $52.0 million (Q1 2026), $123.0 million (Q4 2025), and $515.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 571.00 Mn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 143.00 Mn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | - |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 31.00 Mn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 145.00 Mn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | - |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | - |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 145.00 Mn |
| Jun 30, 2026 | 145.00 Mn |
| Mar 31, 2026 | 52.00 Mn |
| Mar 31, 2026 | 52.00 Mn |
| Dec 31, 2025 | 123.00 Mn |
| Dec 31, 2025 | 123.00 Mn |
| Sep 30, 2025 | 515.00 Mn |
| Sep 30, 2025 | 515.00 Mn |
| Jun 30, 2025 | 175.00 Mn |
| Jun 30, 2025 | 175.00 Mn |
| Mar 31, 2025 | 223.00 Mn |
| Mar 31, 2025 | 223.00 Mn |
| Dec 31, 2024 | 226.00 Mn |
| Dec 31, 2024 | 226.00 Mn |
| Sep 30, 2024 | 85.00 Mn |
| Sep 30, 2024 | 85.00 Mn |
| Jun 30, 2024 | 70.00 Mn |
| Jun 30, 2024 | 70.00 Mn |
| Mar 31, 2024 | 45.00 Mn |
| Mar 31, 2024 | 45.00 Mn |